SCHEMBL5332634

SCHEMBL5332634

CCCC(CCCc1cc[c]cc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.41
SIGMAR1 Q99720 4/20 0.39
KCNH2 Q12809 3/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD1 P21728 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP19A1 P11511 2/20 0.35
KDM4A O75164 1/20 0.35
AOC3 Q16853 1/20 0.34
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11712943 0.90 CYP19A1 (0.39) HTR2ASIGMAR1KCNH2SLC6A2SLC6A4
SCHEMBL6468709 0.89 HTR2A (0.47) HTR2ASIGMAR1KCNH2CHRM2HTR1A
SCHEMBL28775673 0.89 SIGMAR1 (0.47) HTR2ASIGMAR1KCNH2CHRM2HTR1A
SCHEMBL6570932 0.87 CYP19A1 (0.46) SIGMAR1KCNH2CYP19A1
SCHEMBL28163887 0.82 ESR1 (0.53) HTR2ASIGMAR1KCNH2HTR1ASLC6A2
SCHEMBL10437920 0.79 CYP19A1 (0.43) HTR2AESR1ESR2CYP19A1
SCHEMBL11877259 0.79 RIPK1 (0.44) HTR2ASIGMAR1KCNH2CHRM2HTR1A
SCHEMBL1170712 0.79 CYP19A1 (0.40) HTR2ASIGMAR1KCNH2SLC6A2SLC6A4
SCHEMBL6283206 0.78 CYP19A1 (0.47) HTR2ASIGMAR1KCNH2CHRM2HTR1A
SCHEMBL28031202 0.78 ESR1 (0.38) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO claimed
US-20230220294-A1 LUBRICANT COMPOSITION COMPRISING A 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE ALKYL POLYCARBOXYLATE COMPOUND TOTALENERGIES ONETECH (FR) 2023-07-13 US disclosed
EP-1760095-A2 Emulsifier for emulsion polymerization, production method of polymer emulsion and polymer emulsion Dai-Ichi Kogyo Seiyaku Co., Ltd. (JP) 2007-03-07 EP disclosed
US-20070049687-A1 Emulsifier for emulsion polymerization, production method of polymer emulsion and polymer emulsion DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2007-03-01 US disclosed
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-0354871-B1 Corrosion inhibition CIBA GEIGY AG (CH) 1993-11-24 EP disclosed
US-5176850-A Corrosion Inhibitors CIBA-GEIGY CORPORATION (US) 1993-01-05 US disclosed
US-5013482-A Ether acids CIBA-GEIGY CORPORATION (US) 1991-05-07 US disclosed